Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
Rajesh T. Gandhi, Roger Bedimo, Jennifer Hoy, et al.
JAMA (2022) Vol. 329, Iss. 1, pp. 63-63
Closed Access | Times Cited: 375

Showing 1-25 of 375 citing articles:

Prevention, treatment and cure of HIV infection
Raphael J. Landovitz, Hyman Scott, Steven G. Deeks
Nature Reviews Microbiology (2023) Vol. 21, Iss. 10, pp. 657-670
Closed Access | Times Cited: 79
Important considerations regarding the widespread use of doxycycline chemoprophylaxis against sexually transmitted infections
Fabian Kong, Chris Kenyon, Magnus Unemo
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 7, pp. 1561-1568
Open Access | Times Cited: 44
Virological Failure After Switch to Long-Acting Cabotegravir and Rilpivirine Injectable Therapy: An In-depth Analysis
Berend J. van Welzen, S.F.L. van Lelyveld, G. ter Beest, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 1, pp. 189-195
Open Access | Times Cited: 27
Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel
Paul E. Sax, Melanie Thompson, Michael S. Saag
JAMA (2024) Vol. 331, Iss. 12, pp. 1060-1060
Closed Access | Times Cited: 23
Profiling the Interaction between Human Serum Albumin and Clinically Relevant HIV Reverse Transcriptase Inhibitors
Andreia Costa-Tuna, Otávio Augusto Chaves, Zaida L. Almeida, et al.
Viruses (2024) Vol. 16, Iss. 4, pp. 491-491
Open Access | Times Cited: 23
Filling in the Gaps: Updates on Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections
Aniruddha Hazra, Moira McNulty, Maria Pyra, et al.
Clinical Infectious Diseases (2024)
Closed Access | Times Cited: 18
Antiretrovirals and Weight Change: Weighing the Evidence
David A. Wohl, John R. Koethe, Paul E. Sax, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 4, pp. 999-1005
Closed Access | Times Cited: 18
Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series
Alison K. Cohen, Toni Wall Jaudon, Eric M. Schurman, et al.
Communications Medicine (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 2
Evaluating the Efficacy of Repurposed Antiretrovirals in Hepatitis B Virus Treatment: A Narrative Review of the Pros and Cons
Samuel Chima Ugbaja, Simon Achi Omerigwe, S Ndlovu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 925-925
Open Access | Times Cited: 2
Stability, sensitivity, and bifurcation analysis of a fractional-order HIV model of CD$$4^+$$ T cells with memory and external virus transmission from macrophages
Purnendu Sardar, Santosh Biswas, Krishna Pada Das, et al.
The European Physical Journal Plus (2025) Vol. 140, Iss. 2
Closed Access | Times Cited: 2
Delving Into Nanoparticle Systems for Enhanced Drug Delivery Technologies
Nimra Abaidullah, Khalid Muhammad, Yasir Waheed
AAPS PharmSciTech (2025) Vol. 26, Iss. 3
Closed Access | Times Cited: 2
In Vivo HIV Dynamics, Modeling the Interaction of HIV and Immune System via Non-Integer Derivatives
Asif Jan, H. M. Srivastava, Amin Khan, et al.
Fractal and Fractional (2023) Vol. 7, Iss. 5, pp. 361-361
Open Access | Times Cited: 41
Mpox and HIV: a Narrative Review
Carlos Saldana, Colleen F. Kelley, Bruce Aldred, et al.
Current HIV/AIDS Reports (2023) Vol. 20, Iss. 4, pp. 261-269
Open Access | Times Cited: 41
Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study
Jienchi Dorward, Yukteshwar Sookrajh, Thokozani Khubone, et al.
The Lancet HIV (2023) Vol. 10, Iss. 5, pp. e284-e294
Open Access | Times Cited: 37
Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy
Bernard Surial, Frédérique Chammartin, José Damas, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 5, pp. 729-737
Open Access | Times Cited: 32
Weight Gain After HIV Therapy Initiation: Pathophysiology and Implications
Nomathemba Chandiwana, Mark J. Siedner, Vincent C. Marconi, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 2, pp. e478-e487
Open Access | Times Cited: 30
Prevention strategies for sexually transmitted infections, HIV, and viral hepatitis in Europe
Deniz Gökengin, Teymur Noori, Andrea Alemany, et al.
The Lancet Regional Health - Europe (2023) Vol. 34, pp. 100738-100738
Open Access | Times Cited: 30
Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review
Kaiming Tao, Soo‐Yon Rhee, Carolyn Chu, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1932-1932
Open Access | Times Cited: 24
Prophylaxis Against Pneumocystis jirovecii Pneumonia in Adults
Shiwei Zhou, Samuel L Aitken
JAMA (2023) Vol. 330, Iss. 2, pp. 182-182
Closed Access | Times Cited: 23
Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens
Simiso Sokhela, François Venter, Bronwyn Bosch, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 3
Open Access | Times Cited: 13
A Review of FDA-Approved Anti-HIV-1 Drugs, Anti-Gag Compounds, and Potential Strategies for HIV-1 Eradication
Belgin Sever, Masami Otsuka, Mikako Fujita, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3659-3659
Open Access | Times Cited: 13
Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel
Rajesh T. Gandhi, Raphael J. Landovitz, Paul E. Sax, et al.
JAMA (2024)
Closed Access | Times Cited: 13
Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management
Ilana S. Nazari, Matthew J. Feinstein
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 1
Closed Access | Times Cited: 10
Combating antimicrobial resistance in malaria, HIV and tuberculosis
Maëlle Duffey, Robert W. Shafer, Juliano Timm, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 6, pp. 461-479
Closed Access | Times Cited: 9
Event-driven PrEP beyond cisgender men who have sex with men
Whitney C. Irie, Melanie R. Nicol, Meredith E. Clement, et al.
The Lancet HIV (2025)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top